Arora Alisha, Lowe Lori, Su Lyndon, Rees Riley, Bradford Carol, Cimmino Vincent C, Chang Alfred E, Johnson Timothy M, Sabel Michael S
Department of Surgery, University of Michigan, Ann Arbor, Michigan 48105, USA.
Cancer. 2005 Oct 1;104(7):1462-7. doi: 10.1002/cncr.21311.
Adjuvant radiation has been proposed for the treatment of patients with desmoplastic melanoma, who reportedly have local recurrence rates as high as 40-60%. The authors investigated local recurrence rates at a tertiary referral center to determine the success of wide excision alone for patients with desmoplastic melanoma.
A review of a prospectively maintained melanoma clinical data base identified 65 patients between March 1997 and March 2004 with pure cutaneous desmoplastic melanoma. Complete surgical, histopathologic, and staging information was collected along with data on outcome, including local, regional, and distant recurrence and survival.
Similar to previous reports, patients with desmoplastic melanoma had a male-to-female ratio of 2 to 1, a mean age of 65.0 years (range, 31-92 yrs), and the majority of their tumors (55%) were located on the head and neck. The mean Breslow depth at diagnosis was 4.21 mm, with 38% of tumors thicker than 4.0 mm. All patients in this series underwent wide excision without radiation therapy. Surgical margins < or = 2 cm were obtained for all trunk and extremity lesions and for 63% of head and neck lesions that measured > 1 mm in depth (63%). Margins of 1-2 cm were obtained for the remaining patients. Among 49 patients who had a minimum of 2 years of follow-up (mean, 3.7 yrs), the local recurrence rate was 4% (2 of 49 patients). Seventy-eight percent of the patients studied remained alive with no evidence of disease.
Local recurrence rates in the current series were considerably lower than the historically reported rates. This finding suggests that, for patients with desmoplastic melanoma, wide local excision with careful attention to appropriate margins produces excellent local control rates without the need for adjuvant radiation.
促纤维增生性黑色素瘤患者的局部复发率据报道高达40%-60%,有人提出辅助放疗可用于此类患者的治疗。作者在一家三级转诊中心调查了局部复发率,以确定单纯广泛切除对促纤维增生性黑色素瘤患者的治疗效果。
回顾一个前瞻性维护的黑色素瘤临床数据库,确定了1997年3月至2004年3月期间65例单纯皮肤促纤维增生性黑色素瘤患者。收集了完整的手术、组织病理学和分期信息以及结局数据,包括局部、区域和远处复发及生存情况。
与既往报道相似,促纤维增生性黑色素瘤患者的男女比例为2:1,平均年龄65.0岁(范围31-92岁),且其大多数肿瘤(55%)位于头颈部。诊断时的平均Breslow深度为4.21mm,38%的肿瘤厚度超过4.0mm。本系列所有患者均接受了广泛切除,未进行放疗。所有躯干和四肢病变以及63%深度>1mm的头颈部病变(63%)的手术切缘为≤2cm。其余患者的切缘为1-2cm。在49例至少随访2年(平均3.7年)的患者中,局部复发率为4%(49例患者中有2例)。78%的研究患者仍存活且无疾病证据。
本系列中的局部复发率显著低于既往报道的复发率。这一发现表明,对于促纤维增生性黑色素瘤患者,仔细关注合适切缘的广泛局部切除可产生极佳的局部控制率,无需辅助放疗。